Roncoleukin na karnuka

Pin
Send
Share
Send

Magungunan "Roncoleukin" na cikin nau'ikan rigakafin rigakafi kuma ana samunsu a cikin hanyar allura mai sauƙin amfani. Ana ba da shawarar kayan aikin don amfani da magungunan karnuka don magance cututtuka da yawa na nau'ikan nau'ikan tsanani da kuma matsayin magani don rigakafi. Wannan maganin an kirkireshi ne bisa tsarin dan adam interleukin-2 kuma yana da tarin aikace-aikace a aikin likitan dabbobi na zamani.

Rubuta magani

Wannan nau'in ingantaccen kwayar rigakafin kwayar cutar an keɓe shi daga ƙwayoyin yisti, saboda haka farashin sa yana da araha ga yawancin masu kare. ILirƙirar IL-2 tana da tasiri mafi tasiri akan T-lymphocytes, yayin da tabbatar da ƙaruwarsu zai ƙaruwa.

Tasirin ilmin halitta na IL-2 ya ƙunshi tasirin tasiri na mai aiki akan haɓakar, bambance-bambance da kunnawa na monocytes, lymphocytes, macrophages, da ƙwayoyin oligodendroglial da tsarin salula na Langerhans. Ana nuna alamun amfani:

  • rashin daidaito mai saurin canzawa;
  • haɗakar rashin ƙarfi;
  • m peritonitis;
  • m pancreatitis;
  • osteomyelitis;
  • endometritis;
  • ciwon huhu mai tsanani;
  • sepsis;
  • sepsis bayan haihuwa;
  • tarin fuka na huhu;
  • sauran cututtukan gama gari da masu tsanani;
  • kamuwa da konewar zafi da na sinadarai;
  • yadawa da kuma siffofin gama gari na yau da kullun na mummunan cuta;
  • staphylococcus;
  • eczema;
  • mashako;
  • scabies;
  • annoba da shiga ciki;
  • keratitis da rhinitis;
  • chlamydia;
  • konewa ko sanyi;
  • leptospirosis.

Fadada sashin tasirin tasirin tasirin tasirin kwayar halittar sakamakon tasirin kwayoyin halittu masu kama da cuta, kwayoyin cuta da kwayoyin cuta, wadanda ke ba da kariya ta kariya da nufin yakar kwayoyin cuta, da kuma lalata kwayoyin cuta na kwayar cuta, kwayar cuta da fungal.

Kwarewar amfani da magani "Roncoleukin" a matsayin wakili mai hana yaduwa don hana ci gaban cututtukan ido ko yanayin damuwa an yi nazari sosai. Hakanan ya dace don amfani da "Roncoleukin" a gaban aikin rigakafi da kuma bayan rigakafin rigakafin a cikin dabbobin gida mai ƙafa huɗu, idan ya cancanta, don ƙarfafa rigakafi a cikin dabba mai rauni ko tsoho.

Saboda yanayin da yake da shi na musamman, "Roncoleukin" yana iya yaƙar mummunan tasirin raunin da ya faru mai tsanani ko kuma rikitarwa, kuma yana saukaka damuwa mai tsawo.

Mai rigakafin maganin yana aiki da kyau tare da kowane nau'in kwayoyi, gami da magunguna masu yawan kumburi marasa amfani da maganin alurar riga kafi. Banda ana wakiltar keɓaɓɓu ta shirye-shiryen dauke da corticosteroids da glucose.

Abun da ke ciki, nau'in saki

Abubuwan da ke tattare da nau'in sashi ya haɗa da relebinant interleukin-2, da kuma wasu kayan haɗin agaji waɗanda sodium lauryl sulfate, ammonium bicarbonate, mannitol, dithiothreitol da ruwa suka wakilta. Ana samun maganin a cikin hanyar ingantaccen bayani, wanda aka yi niyya don allurar subcutaneous da intravenous.

Yin amfani da allurai a ƙarƙashin fata ya haɗa da ƙari na 1.5-2.0 ml na 0.9% sodium chloride bayani ko ruwan allura na musamman ga maganin. Ana aiwatar da maganin cikin magudanar ta hanyar mai ɗorawa, wanda shine mafi kyawun zaɓi don dabbobin da suka raunana ko kuma suka kamu da ciwo mai tsanani.

Yana da ban sha'awa! Za a iya amfani da miyagun ƙwayoyi don cusa dabba a cikin hanci ko kuma don gabatar da shi ta hanyar catheter a cikin mafitsara tare da cystitis ko wasu cututtukan cututtukan fitsari.

Lokacin da aka sarrafa ta baki, ana narkar da abin da ke cikin kwalba ko ampoule a cikin mili 10 na sodium chloride, bayan haka za a sha maganin a hankali a hankali a sha ga dabbar dabba. Kadan akasari, likitocin dabbobi ne suka tsara magungunan "Roncoleukin" don amfanin waje. A wannan yanayin, ana jika raunukan purulent tare da maganin rigakafin rigakafi ko magance kumburi.

Umarnin don amfani

A cikin umarnin don amfani a haɗe da miyagun ƙwayoyi "Roncoleukin", akwai umarni da yawa game da amfani da lissafin sashi, wanda kai tsaye ya dogara da nauyin dabbar dabba da halaye na ilimin cututtuka.

Idan an tsara wakili don dalilai na warkewa, ana bada shawara don bin waɗannan sashi masu zuwa:

  • cututtukan da kowane kwayar microflora, ƙwayoyin cuta ko fungal ke haifarwa na buƙatar allurar magani. Sashin yana kusan 10,000-15,000 IU a kowace kilogram na nauyin dabba. Likitan likitan dabbobi ya naɗa allura daga biyu zuwa biyar don dacewa da tazarar yau da kullun;
  • game da cutar kansa, likitan dabbobi ya rubuta allurai biyar. A wannan yanayin, an zaɓi sashi a ƙimar 15,000-20,000 IU ga kowane kilogram na nauyin jikin dabbar. Ana maimaita darussan kowane wata.

Don dalilai masu kariya, ana ba da shawarar yin biyayya ga tsarin likitanci mai zuwa don maganin "Roncoleukin"

  • a matakin allurar riga-kafi, ana yin allurar ta karkashin kasa a dai-dai lokacin da ake yin allurar ko wata rana kafin ta. Ana amfani da miyagun ƙwayoyi a nauyin 5000 IU a kowace kilogram na nauyin dabba;
  • motsa rigakafi don hana lalacewar fungal ko cututtukan cututtuka ana yin su ne a cikin nauyin 5000 IU a kowace kilogram na nauyin jikin dabbar;
  • don hana ci gaban rikice-rikicen bayan fida, ana yin allurar maganin da aka shirya kafin ko kuma nan da nan bayan tiyata, da kuma bayan 'yan kwanaki a gwargwadon nauyin 5000 IU / kg;
  • rigakafin shan magani na yanayin damuwa yayin jigilar kayayyaki na dogon lokaci, yayin baje kolin baje kolin ko ziyarar likitan dabbobi ya kunshi gabatar da magungunan ‘yan kwanaki kafin a tona asirin damuwar;
  • don dawo da rigakafin tsoffin dabbobin gida da raunana, ana yin lissafin maganin gwargwadon amfani da 10,000 IU / kg. Allurai biyu kawai ake yi tare da tazarar kwana biyu.

Lokacin da ake ba da umarnin maganin rigakafin "Roncoleukin", ya kamata a tuna cewa maimaita karatun kwaskwarima ana gudanar da shi sosai kamar yadda likitan dabbobi ya umurta bayan watanni uku zuwa shida.

Contraindications

Babban iyakancin da ke shafar nadin magani "Roncoleukin" shine kasancewar rashin kuzari a cikin kare ga abin da yake aiki - interleukin, kazalika da rashin lafiyan yin laushi da yisti ko kasancewar duk wata cuta ta jiki a tarihin dabbobi.

Tare da kulawa sosai kuma a ƙananan allurai, koyaushe ƙarƙashin kulawar likitan dabbobi, an tsara rigakafin rigakafin zamani "Roncoleukin" a cikin maganin cututtukan da aka gabatar ta:

  • raunuka na tsarin gudanarwar zuciya;
  • cututtuka na gudanawar jini da / ko tsarin kwayar halitta;
  • lahani na bawul na zuciya;
  • tsananin gazawar huhu.

Numberananan lambobin hana sababi sun kasance ne ta hanyar hanya ta musamman ta samun sabon ƙarni na rigakafi, da kuma tsabtar ɗabi'un kayan da aka yi amfani da su don samun magani "Roncoleukin".

Matakan kariya

Duk abubuwan da suka hada da kwayoyin sunadarai sun tabarbare da sauri, saboda haka dole ne a adana magungunan rigakafi a cikin firiji a zazzabin 2-9game daC. Maganin da aka kunshi yana da matsakaicin rayuwa na watanni 24 kawai.

Mahimmanci! Raba shan maganin rigakafi tare da kwayoyi masu dauke da sinadarin glucose, kuma za a iya soke tasirin maganin Roncoleukin gaba daya ta hanyar corticosteroids.

Ampoule bayan buɗewa yakamata ayi amfani dashi cikin awanni 24. A cikin bututun da aka hatimce, rigakafin rigakafin yana riƙe da kaddarorin na kimanin makonni biyu. Kafin amfani, yana da mahimmanci a kula da bayyanar ruwa, wanda yakamata ya kasance mai haske, ba tare da dunƙulen ƙugu ba, yatsun kafa da turbidity.

Sakamakon sakamako

Wucewa kan sashin da likitan dabbobi ya tsara yana tare da tachycardia, zazzaɓi, rage hauhawar jini, da fatar jiki.

Yawancin lokaci, yanayin dabba yakan daidaita kansa kai tsaye bayan an daina amfani da maganin, kuma ya kamata a dakatar da halayen rashin lafiyan da haɓaka yanayin zafin jiki tare da magungunan ƙwayoyi, ciki har da magungunan ƙwayoyin cuta masu saurin kumburi da analeptics na zamani.

Yana da ban sha'awa! A wurin allurar, shigarwar jiki da jan ido wani lokaci na iya bayyana, wanda galibi yakan tafi da kansu cikin kwanaki uku kuma ba sa bukatar magani.

Kudin maganin rigakafi "Roncoleukin" na karnuka

Magungunan "Roncoleukin" a cikin hanyar mafita ana kunshe shi a cikin ampoules da nau'uka daban-daban, don haka farashin irin wannan mai ba da izinin rigakafin rigakafin ya bambanta:

  • farashin ampoule na 1 ml na 50,000 IU a cikin kunshin lamba 3 shine 210 rubles;
  • farashin ampoule na 1 ml na 100,000 IU a cikin kunshin lamba 3 shine 255 rubles;
  • farashin ampoule na 1 ml 250,000 IU a cikin kunshin lamba 3 shine 350 rubles;
  • farashin ampoule na 1 ml na 500,000 IU a cikin kunshin lamba 3 shine 670 rubles;
  • farashin ampoule na 1 ml na 2,000,000 IU a cikin kunshin lamba 3 shine 1600-1700 rubles.

Hakikanin farashin magani a shagunan sayar da magani na dabbobi na iya bambanta gwargwadon yankin da kuma farashin farashin wurin sayarwa.

Yana da ban sha'awa! "Roncoleukin" shine mai daidaitaccen daidaitacce, mai kasafin kuɗi da tasiri mai zuwa na zamani, wanda aka kirkireshi tun asali azaman magani ga mutane, don haka kuɗinsa bazai iya zama ƙasa da ƙasa ba.

Bayani game da miyagun ƙwayoyi "Roncoleukin"

Saboda keɓaɓɓen kayan aikinsa da fasahar kera shi, sabon kwayar da ke rigakafin rigakafin "Roncoleukin" ba shi da alamun analo a yanzu. A cikin yanayin magungunan dabbobi na zamani, ana amfani da yawancin masu ba da magani na farashi da abubuwa daban-daban a yau, nau'ikan waɗanda suka haɗa da Interferon, Altevir da Famvir, amma a cikin maganin Roncoleukin ne sauran abubuwan ke ƙunshe. Ta mahangar ilmin sunadarai, har yanzu bai yiwu a hada irin waɗannan abubuwa masu aiki ba.

Magunguna kawai da ke kusa da wanda aka yiwa bayani game da aikin warkewa shine yau "Bioleukin", wanda ya ƙunshi interleukin... Koyaya, bisa ga yawancin likitocin dabbobi, zaɓi na farko a cikin maganin cututtukan cuta da yawa ya zama mafi kyau fiye da ra'ayin mahaɗan kwayar cutar.

Hakanan zai zama mai ban sha'awa:

  • Pirantel don karnuka
  • Advancedtix don karnuka
  • Maxidine don karnuka
  • Karfa don karnuka

Wararrun masu kiwon kare sun daɗe suna lura cewa dabbobin gidan kowane zamani suna haƙuri da gwamnatin Roncoleukin a sauƙaƙe, kuma tare da tsananin bin tsarin kulawa, alamun alamun gaba ɗaya basa nan, kuma tasirin yana ci gaba kuma yana da girma.

Pin
Send
Share
Send

Kalli bidiyon: The harm of abusing Ketamine (Yuni 2024).